New strategy for reversing biofilm-associated antibiotic resistance through ferrocene-substituted carborane ruthenium(II)-arene complex

Science China Chemistry

Volumn 56, Issue 5, 2013, Pages 595-603

  Li, Shuihong ^a   Wu, Changyu ^a   Tang, Xiao ^b   Gao, Shengping ^a   Zhao, Xinqing ^c   Yan, Hong ^b   Wang, Xuemei ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

antibiotic resistance; bacterial biofilms; carborane ruthenium(II) arene complex

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIAL BIOFILM; BACTERIAL INFECTIONS; BIOFILM FORMATION; ENHANCED SENSITIVITY; EXTRACELLULAR MATRIX PROTEIN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTIBIOTICS; ANTIMICROBIAL AGENTS; BACTERIA; BIOFILMS; ORGANOMETALLICS; RUTHENIUM;

RUTHENIUM COMPOUNDS;

EID: 84877817799     PISSN: 16747291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11426-012-4812-6     Document Type: Article

References (41)

1. Liu HL, Chen JN, Jiang J, Giesy JP, Yu HX, Wang XR. Cytotoxicity of HC Orange NO. 1 to L929 fibroblast cells. Environ Toxicol Phar, 2008, 26: 309-314
2. Potera C. Forging a link between biofilms and disease. Science, 1999, 283: 1837-1839
3. Davey ME, O'toole GA. Microbial biofilms: From ecology to molec ular genetics. Microbiol Mol Biol R, 2000, 64: 847-867
4. Smith K, Perez A, Ramage G, Gemmell CG, Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clin-damycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Ag, 2009, 33: 374-378
5. Gilbert P, Das J, Foley I. Biofilm susceptibility to antimicrobials. Adv Dent Res, 1997, 11: 160-167
6. Lefebvre F, Putaj P, Basset JM, Wang XX, Fu XZ. Modification of the adsorption and catalytic properties of micro- and mesoporous materials by reactions with organometallic complexes. Science China-chemistry, 2010, 53: 1862-1869
7. Fish RH, Jaouen G. Bioorganometallic chemistry: Structural diversity of organometallic complexes with bioligands and molecular recognition studies of several supramolecular hosts with biomolecules, alkalimetal ions, and organometallic pharmaceuticals. Organometallics, 2003, 22: 2166-2177
8. van Staveren DR, Metzler-Nolte N. Bioorganometallic chemistry of ferrocene. Chem Rev, 2004, 104: 5931-5985
9. Chantson JT, Falzacappa MVV, Crovella S, Metzler-Nolte N. Antibacterial activities of ferrocenoyl- and cobaltocenium-peptide bioconjugates. J Organomet Chem, 2005, 690: 4564-4572
10. Asghar F, Badshah A, Shah A, Rauf MK, Ali MI, Tahir MN, Nosheen E, Rehman Z, Qureshi R. Synthesis, characterization and DNA binding studies of organoantimony(V) ferrocenyl benzoates. J Organomet Chem, 2012, 717: 1-8
11. Arbi ME, Pigeon P, Top S, Rhouma A, Aifa S, Rebai A, Vessières A, Plamont MA, Jaouen G. Evaluation of bactericidal and fungicidal activity of ferrocenyl or phenyl derivatives in the diphenyl butene series. J Organomet Chem, 2011, 696: 1038-1048
12. Plazuk D, Rychlik B, Blauz A, Domagała S. Synthesis, electrochemistry and anticancer activity of novel ferrocenyl phenols prepared via azide-alkyne 1,3-cycloaddition reaction. J Organomet Chem, 2012, 715: 102-112
13. Ornelas C. Application of ferrocene and its derivatives in cancer research. New J Chem, 2011, 35: 1973-1985
14. Delhaes L, Biot C, Berry L, Delcourt P, Maciejewski LA, Camus D, Brocard JS, Dive D. Synthesis of ferroquine enantiomers: First investigation of effects of metallocenic chirality upon antimalarial activity and cytotoxicity. ChemBioChem, 2002, 3: 418-423
15. Biot C, Taramelli D, Forfar-Bares I, Maciejewski LA, Boyce M, Nowogrocki G, Brocard JS, Basilico N, Olliaro P, Egan TJ. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Mol Pharmaceutics, 2005, 2: 185-193
16. Biot C, Delhaes L, Abessolo H, Domarle O, Maciejewski LA, Mortuaire M, Delcourt P, Deloron P, Camus D, Dive D, Brocard JS. Novel metallocenic compounds as antimalarial agents. Study of the position of ferrocene in chloroquine. J Organomet Chem, 1999, 589: 59-65
17. Jaouen G, Top S, Vessieres A, Leclercq G, McGlinchey MJ. The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer. Curr Med Chem, 2004, 11: 2505-2517
18. Top S, Vessieres A, Leclercq G, Quivy J, Tang J, Vaissermann J, Huche M, Jaouen G. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: Evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines. Chem-Eur J, 2003, 9: 5223-5236
19. Edwards EI, Epton R, Marr G. Organometallic derivatives of penicillins and cephalosporins a new class of semi-synthetic antibiotics. J Organomet Chem, 1975, 85: C23-C25
20. Edwards EI, Epton R, Marr G. A new class of semi-synthetic antibiotics: Ferrocenyl-penicillins and -cephalosporins. J Organomet Chem, 1976, 107: 351-357
21. Valliant JF, Guenther KJ, King AS, Morel P, Schaffer P, Sogbein OO, Stephenson KA. The medicinal chemistry of carboranes. Coord Chem Re, 2002, 232: 173-230
22. Wu CH, Ye HD, Jiang H, Wang XM, Yan H. Study on specific interaction of new ferrocene-substituted carborane conjugates with hemoglobin protein. Sci China Chem, 2012, 55: 594-603
23. Armstrong AF, Valliant JF. The bioinorganic and medicinal chemistry of carboranes: From new drug discovery to molecular imaging and therapy. Dalton T, 2007, 4240-4251
24. Li SH, Wu CY, Lv XY, Tang X, Zhao XQ, Yan H, Jiang H, Wang XM. Discovery of ferrocene-carborane derivatives as novel chemical antimicrobial agents against multidrug-resistant bacteria. Sci China Chem, 2012, 55: 2388-2395
25. Bregadze VI, Sivaev IB, Glazun SA. Polyhedral boron compounds as potential diagnostic and therapeutic antitumor agents. Anticancer Agents Med Chem, 2006, 6: 75-109
26. Soloway AH, Tjarks W, Barnum BA, Rong FG, Barth RF, Codogni IM, Wilson JG. The chemistry of neutron capture therapy. Chem Rev, 1998, 98: 1515-1562
27. Miyajima Y, Nakamura H, Kuwata Y, Lee JD, Masunaga S, Ono K, Maruyama K. Transferrin-loaded nido-carborane liposomes: Tumor-targeting boron delivery system for neutron capture therapy. Bioconjugate Chem, 2006, 17: 1314-1320
28. Wu CH, Wu DH, Liu X, Guoyiqibayi G, Guo DD, Lv G, Wang XM, Yan H, Jiang H, Lu ZH. Ligand-based neutral ruthenium(II) arene complex: Selective anticancer action. Inorg chem, 2009, 48: 2352-2354
29. Wu DH, Wu CH, Li YZ, Guo DD, Wang XM, Yan H. Addition of ethynylferrocene to transition-metal complexes containing a chelating 1,2-dicarba-closo- dodecaborane-1,2-dichalcogenolate ligand - in vitro cooperativity of a ruthenium compound on cellular uptake of an anticancer drug. Dalton T, 2009, 285-290
30. Wu C, Ye H, Bai W, Li Q, Guo D, Lv G, Yan H, Wang X. New potential anticancer agent of carborane derivatives: Selective cellular interaction and activity of ferrocene-substituted dithio-o-carborane conjugates. Bioconjugate Chem, 2011, 22: 16-25
31. Xu BH, Peng XQ, Li YZ, Yan H. Reactions of 16e CpCo half-sandwich complexes containing a chelating 1,2-dicarba-closo-dodecaborane-1,2- dichalcogenolate ligand with ethynylferrocene and dimethyl acetylenedicarboxylate. Chem-Eur J, 2008, 14: 9347-9356
32. Xu BH, Peng XQ, Xu ZW, Li YZ, Yan H. Cobalt(III)-mediated disulfuration and hydrosulfuration of alkynes. Inorg Chem, 2008, 47: 7928-7933
33. Wu C, Xu B, Zhao J, Jiang Q, Wei F, Jiang H, Wang X, Yan H. Ferrocene-substituted dithio-o-carborane isomers: Influence on the native conformation of myoglobin protein. Chem-Eur J, 2010, 16: 8914-8922
34. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard, 8th ed, Document M7-A8, Wayne, PA: CLSI, 2008
35. Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML. Microplate alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Ch, 2005, 49: 2612-2617
36. Hirose I, Sano K, Shioda I, Kumano M, Nakamura K, Yamane K. Proteome analysis of Bacillus subtilis extracellular proteins: A two-dimensional protein electrophoretic study. Microbiology+, 2000, 146: 65-75
37. Tunney MM, Ramage G, Field TR, Moriarty TF, Storey DG. Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Antimicrob Agents Ch, 2004, 48: 1879-1881
38. Kwon AS, Park GC, Ryu SY, Lim DH, Lim DY, Choi CH, Park Y, Lim Y. Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus. Int J Antimicrob Ag, 2008, 32: 68-72
39. Corrigan RM, Rigby D, Handley P, Foster TJ. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology+, 2007, 153: 2435-2446
40. Mengodin E, Bajolet O, Cutrona J, Bonnet N, Dupuit F, Puchelle E, de Bentzmann S. Fibronectin-binding proteins of Staphylococcus aureus are involved in adherence to human airway epithelium. Infect Immun, 2002, 70: 620-630
41. Joh D, Wann ER, Kreikemeyer B, Speziale P, Höök M. Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells. Matrix Biol, 1999, 18: 211-223